Abstract:BackgroundEsophageal cancer is a high incident cancer worldwide with poor survival and limited therapeutic options. Alterations of microRNAs are common in cancers, and many of these micro RNAs are potential therapeutic and diagnostic targets to treat these cancers. miR-10b-3p located in chromosome region 2q31.1, and its expression is frequently increased in esophageal squamous cell carcinoma (ESCC). However, the biological functions, clinical significance and therapeutic implications of miR-10b-3p in ESCC remain unclear.MethodsThe expression levels of miR-10b-3p in ESCC specimens were analyzed by in situ hybridization (ISH) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) assays. Ectopic overexpression of miR-10b-3p in ESCC cells, mouse xenograft model, and metastasis model were used to evaluate the effects of miR-10b-3p on proliferation, and migration of cancer cells. Luciferase reporter assay and Western blot were performed to validate the potential targets of miR-10b-3p after the preliminary screening by computer-aided microarray analysis.ResultsWe found that miR-10b-3p expression levels were significantly upregulated in the tumor tissues and serum samples of patients with ESCC. The expression levels of miR-10b-3p in both tumor tissues and serum samples were inversely associated with lymph node metastasis and clinical stages. We identified the expression level of miR-10b-3p in ESCC cancer samples as an independent prognostic marker of the overall survival rates of ESCC patients. We found more frequent hypomethylation of the CpG sites located upstream of the miR-10b-3p gene in the ESCC tissues compared with in the adjacent normal tissues, and the DNA methylation status of miR-10b-3p promoter region inversely correlated with the expression levels of miR-10b-3p. Ectopic overexpression of miR-10b-3p promoted cell proliferation, colony formation, migration and invasion in ESCC. While knockdown of miR-10b-3p had the opposite effects, particularly in promoting apoptosis. Mouse xenograft model confirmed that miR-10b-3p functions as a potent oncogenic miRNA in ESCC, which also promoting ESCC metastasis. Mechanistically, we found miR-10b-3p regulated FOXO3 expression by directly binding to the 3′-untranslated region. And systemic delivery of miR-10b-3p antagomir reduced tumor growth and inhibit FOXO3 protein expression in nude mice.ConclusionsCollectively, our findings suggested upregulated expression of miR-10b-3p caused by promoter hypomethylation contributed to the progression of ESCC; Thus, miR-10b-3p is a potentially effective biomarker for ESCC that could have further therapeutic implications.

MiR-629 Promotes Human Pancreatic Cancer Progression by Targeting FOXO3.

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

MicroRNA-629 Promotes the Tumorigenesis of Non-Small-cell Lung Cancer by Targeting FOXO1 and Activating PI3K/AKT Pathway

MicroRNA-138-5p Regulates Pancreatic Cancer Cell Growth Through Targeting FOXC1.

Mir-517a-3p Accelerates Lung Cancer Cell Proliferation and Invasion Through Inhibiting Foxj3 Expression

Mir-625-3p Promotes Migration and Invasion and Reduces Apoptosis of Clear Cell Renal Cell Carcinoma.

FOXM1-induced miR-552 expression contributes to pancreatic cancer progression by targeting multiple tumor suppressor genes

MicroRNA-221-3p is Related to Survival and Promotes Tumour Progression in Pancreatic Cancer: a Comprehensive Study on Functions and Clinicopathological Value

MiR-940 promotes malignant progression of breast cancer by regulating FOXO3

MiR-27a-regulated FOXO1 Promotes Pancreatic Ductal Adenocarcinoma Cell Progression by Enhancing Wnt/β-catenin Signaling Activity.

Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression

Mir-3682-3p Directly Targets FOXO3 and Stimulates Tumor Stemness in Hepatocellular Carcinoma Via a Positive Feedback Loop Involving FOXO3/PI3K/AKT/c-Myc

miR-630 as a therapeutic target in pancreatic cancer stem cells: modulation of the PRKCI-Hedgehog signaling axis

MiR-629-5p Promotes the Invasion of Lung Adenocarcinoma Via Increasing Both Tumor Cell Invasion and Endothelial Cell Permeability

Mir-130b is A Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer Through Targeting Stat3

MicroRNA‑629 inhibition suppresses the viability and invasion of non‑small cell lung cancer cells by directly targeting RUNX3

FOXO3a Negatively Regulates Mir-155-5p Expression to Impact the Proliferation and Invasion of Renal Cell Carcinoma

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)

FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.